曲帕拉醇治疗后白内障的形成。 - Suppr

Suppr

超能文献

Cataract formation after triparanol therapy.

作者信息

KIRBY T J, ACHOR R W, PERRY H O, WINKELMANN R K

出版信息

Arch Ophthalmol. 1962 Oct;68:486-9. doi: 10.1001/archopht.1962.00960030490010.

DOI:10.1001/archopht.1962.00960030490010

PMID:14456241

Abstract

摘要

相似文献

Cataract formation after triparanol therapy.

Arch Ophthalmol. 1962 Oct;68:486-9. doi: 10.1001/archopht.1962.00960030490010.

Cataracts in patients treated with triparanol.

JAMA. 1962 Jul 28;181:339-40. doi: 10.1001/jama.1962.03050300059020a.

Cataracts as possible complications of treatment with triparanol.

Arch Ophthalmol. 1962 Apr;67:543-4. doi: 10.1001/archopht.1962.00960020543037.

The use of triparanol to lower serum cholesterol.

Am Heart J. 1960 Oct;60:536-8. doi: 10.1016/0002-8703(60)90431-2.

[Teratogenic action of Triparanol].

C R Seances Soc Biol Fil. 1961;155:2255-7.

Inhibition by triparanol of cholesterol formation in the brain of the newborn mouse.

J Neurochem. 1962 Mar-Apr;9:99-103. doi: 10.1111/j.1471-4159.1962.tb11849.x.

A brief experience with triparanol (MER-29).

J Fla Med Assoc (1914). 1961 Oct;48:341-5.

[Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol].

Z Gesamte Inn Med. 1962 Feb 15;17:183-6.

Evaluation of a cholesterol-synthesis inhibitor (triparanol).

Ann Intern Med. 1960 Sep;53:462-7. doi: 10.7326/0003-4819-53-3-462.

[Experiences with Triparanol, a drug inhibiting cholesterol biosynthesis, in atherosclerotic patients].

Orv Hetil. 1962 Apr 15;103:690-2.

引用本文的文献

Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Lipids. 2009 Jun;44(6):477-87. doi: 10.1007/s11745-009-3305-7. Epub 2009 May 14.

THE ESTIMATION OF DESMOSTEROL AND CHOLESTEROL IN PLASMA.

Br Heart J. 1964 Mar;26(2):274-81. doi: 10.1136/hrt.26.2.274.

Intestinal lesions associated with triparanol. A clinical and experimental study.

Am J Dig Dis. 1965 Dec;10(12):1024-33. doi: 10.1007/BF02233376.

The reversal of triparanol-induced cataracts in the rat.

Doc Ophthalmol. 1969;26:324-33. doi: 10.1007/BF00943994.

The lipids in pathology of the eye.

J Am Oil Chem Soc. 1967 Nov;44(11):615-22. doi: 10.1007/BF02680029.

Cataracts produced by triparanol. (MER-29).

Trans Am Ophthalmol Soc. 1967;65:494-543.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cataract formation after triparanol therapy.

Arch Ophthalmol. 1962 Oct;68:486-9. doi: 10.1001/archopht.1962.00960030490010.

Cataracts in patients treated with triparanol.

JAMA. 1962 Jul 28;181:339-40. doi: 10.1001/jama.1962.03050300059020a.

Cataracts as possible complications of treatment with triparanol.

Arch Ophthalmol. 1962 Apr;67:543-4. doi: 10.1001/archopht.1962.00960020543037.

The use of triparanol to lower serum cholesterol.

Am Heart J. 1960 Oct;60:536-8. doi: 10.1016/0002-8703(60)90431-2.

[Teratogenic action of Triparanol].

C R Seances Soc Biol Fil. 1961;155:2255-7.

Inhibition by triparanol of cholesterol formation in the brain of the newborn mouse.

J Neurochem. 1962 Mar-Apr;9:99-103. doi: 10.1111/j.1471-4159.1962.tb11849.x.

A brief experience with triparanol (MER-29).

J Fla Med Assoc (1914). 1961 Oct;48:341-5.

[Clinical trials in atherosclerotics with Triparanol (MER-29) diminishing the biosynthesis of cholesterol].

Z Gesamte Inn Med. 1962 Feb 15;17:183-6.

Evaluation of a cholesterol-synthesis inhibitor (triparanol).

Ann Intern Med. 1960 Sep;53:462-7. doi: 10.7326/0003-4819-53-3-462.

[Experiences with Triparanol, a drug inhibiting cholesterol biosynthesis, in atherosclerotic patients].

Orv Hetil. 1962 Apr 15;103:690-2.

引用本文的文献

Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Lipids. 2009 Jun;44(6):477-87. doi: 10.1007/s11745-009-3305-7. Epub 2009 May 14.

THE ESTIMATION OF DESMOSTEROL AND CHOLESTEROL IN PLASMA.

Br Heart J. 1964 Mar;26(2):274-81. doi: 10.1136/hrt.26.2.274.

Intestinal lesions associated with triparanol. A clinical and experimental study.

Am J Dig Dis. 1965 Dec;10(12):1024-33. doi: 10.1007/BF02233376.

The reversal of triparanol-induced cataracts in the rat.

Doc Ophthalmol. 1969;26:324-33. doi: 10.1007/BF00943994.

The lipids in pathology of the eye.

J Am Oil Chem Soc. 1967 Nov;44(11):615-22. doi: 10.1007/BF02680029.

Cataracts produced by triparanol. (MER-29).

Trans Am Ophthalmol Soc. 1967;65:494-543.